Thursday, November 6, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Reaffirms Positive Outlook on DoubleVerify Holdings with Lower Price Target

Elaine Mendonca by Elaine Mendonca
March 1, 2024
in Breaking News
0
Neurotechnology
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

On March 1, 2024, Brian Pitz, an analyst at BMO Capital, reaffirmed his positive outlook on DoubleVerify Holdings (NYSE:DV) with an Outperform rating. However, he did lower the price target from $44 to $42. This change comes after BMO Capital initiated coverage on DoubleVerify Holdings, with Pitz initially setting a price target of $44. The revised price target suggests a shift in Pitz’s perspective on the company’s future performance and market potential.

DV Stock Price Drops by 2.17% on March 1, 2024 – Investors Advised to Monitor for Potential Catalysts

On March 1, 2024, DV stock experienced a slight drop in performance, with the price of shares decreasing by $0.67 since the market last closed. This represents a 2.17% decrease in value. The stock opened at $31.61, which was $0.72 higher than its previous close. Investors may want to keep an eye on DV stock to see if the downward trend continues or if there are any potential catalysts that could drive the stock price higher in the future.

DV Stock Soars with Impressive Financial Results in 2024

DV stock had a strong performance on March 1, 2024, with impressive financial results that exceeded expectations. According to data from CNN Money, DV reported total revenue of $572.54 million for the past year, showing a significant increase of 26.55% compared to the previous year. In the fourth quarter alone, total revenue reached $172.20 million, marking a 19.6% increase since the previous quarter.

The company’s net income also saw substantial growth, with a total of $71.47 million for the year, representing a 65.17% increase from the previous year. In the fourth quarter, net income reached $33.10 million, showing an impressive 148.03% increase since the previous quarter.

Earnings per share (EPS) for DV stock stood at $0.41 for the year, reflecting a 62.63% increase from the previous year. However, EPS remained flat at $0.19 for the fourth quarter compared to the previous quarter.

Overall, DV stock demonstrated strong financial performance on March 1, 2024, with significant increases in total revenue and net income. Investors may view these results as a positive indicator of the company’s growth and profitability.

Tags: DV
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Financing and finances

Goldman Sachs Analyst Reiterates Sell Rating on Autodesk

Redefining Success: How Franchises Adapt to Economic Shifts and Market Demands

Goldman Sachs Increases Price Target for Elastic NYSE ESTC to 106

GD stock news

Analyst Ratings and Price Targets for Schrodinger NASDAQ SDGR

Recommended

Baidu Stock

Baidu’s Strategic Moves in Autonomous Driving and AI Draw Mixed Investor Reactions

1 month ago

Windtree Therapeutics Achieves Financial Stability and Advances Clinical Programs

2 years ago
Technology Data analytics Stock Bull Market

Anticipation High for Adobes FirstQuarter Financial Results and AI Innovation

2 years ago
Ideaya Biosciences Stock

Ideaya Biosciences: A Tale of Market Skepticism and Clinical Promise

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

EU Grant Provides Critical Boost for LanzaTech’s Carbon Recycling Technology

Is Darden Restaurants Facing a Critical Test?

Critical Juncture for USA Rare Earth as Earnings and Chinese Export Curbs Collide

AES Shares Surge on Potential $38 Billion Acquisition Speculation

Kura Oncology Investors Await Crucial FDA Verdict

Cadence Design Stock: A Battle Between Fundamentals and Market Signals

Trending

DuPont de Nemours Stock
Analysis

DuPont Faces Critical Test as Quarterly Results Loom

by Dieter Jaworski
November 6, 2025
0

DuPont de Nemours finds itself at a pivotal moment as the chemical giant prepares to release quarterly...

Sarepta Therapeutics Stock

Sarepta Therapeutics Shares Plummet Following Critical Clinical Trial Failure

November 6, 2025
Emerson Electric Stock

Emerson Electric’s Strategic Pivot Faces Market Scrutiny

November 6, 2025
Lanzatech Global Stock

EU Grant Provides Critical Boost for LanzaTech’s Carbon Recycling Technology

November 6, 2025
Darden Restaurants Stock

Is Darden Restaurants Facing a Critical Test?

November 6, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • DuPont Faces Critical Test as Quarterly Results Loom
  • Sarepta Therapeutics Shares Plummet Following Critical Clinical Trial Failure
  • Emerson Electric’s Strategic Pivot Faces Market Scrutiny

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com